Restoring neuronal function by protecting microtubules
Breakthrough anti-depressant drugs
A novel therapeutic era in neurology

Top 10 Innovation

logo depsterlogo eurostars

The DEPSTER project, entirely initiated and piloted by MAPREG, was designed to bring revolution to the treatment of Depressive Disorders. It was ranked 6th at the European level and was awarded an EUREKA / EUROSTARS grant.

Learn More »

Orphan drug status

logo depster

Based on its impressive preclinical efficacy and safety, MAP4343 received the european orphan drug status to treat Spinal Cord Injuries, a rare but dreadful situation devoid of any medical solution.

Learn More »

Prestigious supports

 logo oseo  logo eu  logo US army

MAPREG investors trust our technology; their support helps us raise grants for each of our developments.

Learn More »

Where to find us
  • Mapreg

    80 Rue du Général Leclerc,
    94270 Kremlin Bicêtre